Chagas Disease: Update on progress and future perspectives | Médecins Sans Frontières Access Campaign Skip to main content Media room Contact msf.org About us About the Access Campaign Our 2022 wishlist Media room Latest news Jobs Get Involved! Sign up to stay updated and find out how you can get involved. Email Address Data protection consent I want to receive emails from MSF and I have read and agree with the privacy policy. Our work COVID-19 Explainer: A bold proposal at the WTO by India and South Africa Diabetes Drug-resistant infections HIV/AIDS Hepatitis C Hypertension Patents and intellectual property The Patent Oppositions Database Spotlight on: Access to medicines in Europe Spotlight on: TRIPS, TRIPS Plus Research and development Spotlight on: the Big Pharma double-dip Tropical and neglected diseases Spotlight on: Snakebite Tuberculosis Vaccines Explainer: COVID-19 vaccines - Recommendations for equitable access Share the Tech - Save Lives Get Involved! Sign up to stay updated and find out how you can get involved. Email Address Data protection consent I want to receive emails from MSF and I have read and agree with the privacy policy. Get involved Active campaigns No Patents in a Pandemic 20 years of Advocacy in Action Share the Tech - Save Lives Campaign success stories #NoMoreTears Johnson & Johnson Can you hear us? Novartis 'Drop the case' Trans-pacific Partnership (TPP) Take Action Get Involved! Sign up to stay updated and find out how you can get involved. Email Address Data protection consent I want to receive emails from MSF and I have read and agree with the privacy policy. Resources Press releases Statements Letters Opinion articles Feature stories Interviews Blog Newsletters Publications Research articles Topic overview pages Spotlight pages Videos Photo stories Infographics Events Get Involved! Sign up to stay updated and find out how you can get involved. Email Address Data protection consent I want to receive emails from MSF and I have read and agree with the privacy policy. Media room Contact msf.org About us About the Access Campaign Our 2022 wishlist Media room Latest news Jobs Get Involved! Sign up to stay updated and find out how you can get involved. Email Address Data protection consent I want to receive emails from MSF and I have read and agree with the privacy policy. Our work COVID-19 Explainer: A bold proposal at the WTO by India and South Africa Diabetes Drug-resistant infections HIV/AIDS Hepatitis C Hypertension Patents and intellectual property The Patent Oppositions Database Spotlight on: Access to medicines in Europe Spotlight on: TRIPS, TRIPS Plus Research and development Spotlight on: the Big Pharma double-dip Tropical and neglected diseases Spotlight on: Snakebite Tuberculosis Vaccines Explainer: COVID-19 vaccines - Recommendations for equitable access Share the Tech - Save Lives Get Involved! Sign up to stay updated and find out how you can get involved. Email Address Data protection consent I want to receive emails from MSF and I have read and agree with the privacy policy. Get involved Active campaigns No Patents in a Pandemic 20 years of Advocacy in Action Share the Tech - Save Lives Campaign success stories #NoMoreTears Johnson & Johnson Can you hear us? Novartis 'Drop the case' Trans-pacific Partnership (TPP) Take Action Get Involved! Sign up to stay updated and find out how you can get involved. Email Address Data protection consent I want to receive emails from MSF and I have read and agree with the privacy policy. Resources Press releases Statements Letters Opinion articles Feature stories Interviews Blog Newsletters Publications Research articles Topic overview pages Spotlight pages Videos Photo stories Infographics Events Get Involved! Sign up to stay updated and find out how you can get involved. Email Address Data protection consent I want to receive emails from MSF and I have read and agree with the privacy policy. Medicines shouldn’t be a luxury Take action! Get involved Share the Tech If mRNA vaccine technology from Moderna, BioNTech and Pfizer were shared, manufacturers in low- and middle-income countries could produce vaccines for global pandemic preparedness, as well as diseases of concern such as HIV, TB and malaria. Search Sort by DateRelevance toggle menu toggle menu Report | 02 August 2006 Chagas Disease: Update on progress and future perspectives TROPICAL & NEGLECTED DISEASES Download NEGDIS_report_Chagas_UpdateOnProgress_ENG_2006.pdf This document is intended to provide an overview of American trypanosomiasis or Chagas’ disease. It is meant for both medical and non-medical readers, and seeks to present a comprehensive view on both the current situation and future perspectives for the disease, focusing either on the issues where a global consensus does not exist or where an improvement of the situation is generally considered as needed. The information presented here is not intended to replace or amend current national policies. We hope that this document will facilitate efforts to guarantee future wider availability of Chagas’ disease diagnostic and treatment, and stimulate MSF to continue or even increase its valuable work on one of the most neglected tropical diseases. Navigate About the Access Campaign 1999-2019: 20 Years of Advocacy in Action Contact us Get involved Our work Resources Search Get updates Sign up for our newsletter Privacy & data protection information Contact MSF Access Campaign Médecins Sans Frontières Route de Ferney 140 P.O. Box 1224 CH-1211 Geneva 1, Switzerland Phone:+41 22 849 8484 Fax:+41 22 849 8404 E-mail: access(at)msf.org Follow us on Twitter and Facebook Twitter Vimeo Facebook